InnovateUK funding drives commercialisation of cardiovascular clinical decision assist systems
Pioneering software that enables anaesthetists to make better decisions for high-risk patients during surgery has been awarded InnovateUK funding.
Cambridge-based Directed Systems has been allocated a Digital Health Technology Catalyst Round 3 Collaborative R&D grant to develop and market its innovative cardiovascular clinical decision assist systems.
The company will work alongside clinicians at University Hospitals Birmingham NHS Foundation Trust (UHB) to create the technology for operating theatres, intensive care units and emergency departments. ;p>
The aim of the research will be to complete product development, usability and clinical testing, and CE Mark approvals for the clinical decision support software for the UK and European market.
Low blood pressure (hypotension) during operations occurs frequently and is associated with complications and poor outcomes. For patients this means longer hospital stays and in, worst cases, increased risks of mortality.
Evidence shows that reducing hypotension can reduce these side effects.
Once developed, the technology aims to help improve patient outcomes by optimising care and reducing complications. It will also support reducing hospital length of stays and help to save hospitals money.
Dr Mark Leaning, chief executive and founder of Directed Systems, said: “We are delighted to receive this support from InnovateUK. It enables us to build our relationship with UHB and complete our product development.
“Our vision is that our software will make a real difference to patients’ lives, as well as saving the NHS substantial costs.”